Cellectis (CLLS) Assets (2014 - 2026)

Cellectis (CLLS) has 13 years of Assets data on file, last reported at $289.2 million in Q1 2026.

• In Q1 2026, Assets fell 20.57% year-over-year to $289.2 million; the TTM figure through Mar 2026 stood at $289.2 million (down 20.57% YoY), while the FY2025 annual figure was $324.7 million, down 15.34% from the prior year.
• Assets fell to $289.2 million in Q1 2026, from $324.7 million in the prior quarter.
• Across five years, Assets topped out at $407.1 million in Q2 2024 and bottomed at $209.7 million in Q3 2023.
• A 5-year average of $324.2 million and a median of $338.7 million in 2023 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets tumbled 32.29% — and 2024, when it soared 88.78%.
• Year by year, Assets stood at $279.6 million in 2022, then advanced by 19.56% to $334.3 million in 2023, then advanced by 14.74% to $383.5 million in 2024, then retreated by 15.34% to $324.7 million in 2025, then dropped by 10.94% to $289.2 million in 2026.
• The last three Assets figures came in at $289.2 million (Q1 2026), $324.7 million (Q4 2025), and $343.0 million (Q3 2025), per Business Quant data.

Peer Comparison